Anti-CCN3/ IBP-9/ IGFBP-9 functional antibody

Anti-CCN3/ IBP-9/ IGFBP-9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCN3/CCN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0752-Ab-1/ GM-Tg-hg-SE0752-Ab-2Anti-Human CCN3 monoclonal antibodyHuman
GM-Tg-rg-SE0752-Ab-1/ GM-Tg-rg-SE0752-Ab-2Anti-Rat CCN3 monoclonal antibodyRat
GM-Tg-mg-SE0752-Ab-1/ GM-Tg-mg-SE0752-Ab-2Anti-Mouse CCN3 monoclonal antibodyMouse
GM-Tg-cynog-SE0752-Ab-1/ GM-Tg-cynog-SE0752-Ab-2Anti-Cynomolgus/ Rhesus macaque CCN3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0752-Ab-1/ GM-Tg-felg-SE0752-Ab-2Anti-Feline CCN3 monoclonal antibodyFeline
GM-Tg-cang-SE0752-Ab-1/ GM-Tg-cang-SE0752-Ab-2Anti-Canine CCN3 monoclonal antibodyCanine
GM-Tg-bovg-SE0752-Ab-1/ GM-Tg-bovg-SE0752-Ab-2Anti-Bovine CCN3 monoclonal antibodyBovine
GM-Tg-equg-SE0752-Ab-1/ GM-Tg-equg-SE0752-Ab-2Anti-Equine CCN3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0752-Ab-1/ GM-Tg-hg-SE0752-Ab-2; GM-Tg-rg-SE0752-Ab-1/ GM-Tg-rg-SE0752-Ab-2;
GM-Tg-mg-SE0752-Ab-1/ GM-Tg-mg-SE0752-Ab-2; GM-Tg-cynog-SE0752-Ab-1/ GM-Tg-cynog-SE0752-Ab-2;
GM-Tg-felg-SE0752-Ab-1/ GM-Tg-felg-SE0752-Ab-2; GM-Tg-cang-SE0752-Ab-1/ GM-Tg-cang-SE0752-Ab-2;
GM-Tg-bovg-SE0752-Ab-1/ GM-Tg-bovg-SE0752-Ab-2; GM-Tg-equg-SE0752-Ab-1/ GM-Tg-equg-SE0752-Ab-2
Products NameAnti-CCN3 monoclonal antibody
Formatmab
Target NameCCN3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCN3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0752-Ag-1Recombinant multi-species CCN3/ IBP-9/ IGFBP-9 protein
    CytokineGM-Tg-g-SE0752-Ag-1nephroblastoma overexpressed (NOV) protein
    ORF Viral VectorvGMLP003882human NOV Lentivirus particle
    ORF Viral VectorpGMLP003882human NOV Lentivirus plasmid
    ORF Viral VectorpGMLPm001351mouse Nov Lentivirus plasmid
    ORF Viral VectorvGMLPm001351mouse Nov Lentivirus particle


    Target information

    Target IDGM-SE0752
    Target NameCCN3
    Gene ID4856,18133,81526,702196,475083,101097377,505727,100057055
    Gene Symbol and SynonymsC130088N23Rik,CCN3,IBP-9,IGFBP-9,IGFBP9,NOV,NOVh
    Uniprot AccessionP48745,Q9QZQ5
    Uniprot Entry NameCCN3_HUMAN,CCN3_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    Diseasegastric cancer
    Gene EnsemblENSG00000136999
    Target ClassificationN/A

    The target: CCN3, gene name: CCN3, also named as IBP-9, IGFBP-9, IGFBP9, NOV, NOVh. The protein encoded by this gene is a small secreted cysteine-rich protein and a member of the CCN family of regulatory proteins. CNN family proteins associate with the extracellular matrix and play an important role in cardiovascular and skeletal development, fibrosis and cancer development. [provided by RefSeq, Feb 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.